Clinical Trial Update: Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to compare safety and pharmacokinetics after subcutaneous injection of HUC2-676 or HUC2-676-R in healthy adult subjects, with obesity listed as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HUC2-676
• HUC2-676-R

Snippet

Sponsor: Huons Co., Ltd. | Conditions: Obesity | Phase 1 | Status: NOT_YET_RECRUITING